<DOC>
	<DOCNO>NCT02600221</DOCNO>
	<brief_summary>To investigate distribution patient ACOS , asthma COPD age 40 chronic airflow limitation China .</brief_summary>
	<brief_title>A Non-interventional Study Investigate Current Situation Asthma-COPD Overlap Syndrome Patients Over Age 40 With Persistent Airflow Limitation China</brief_title>
	<detailed_description>Sites must tier 3 hospital China . Investigators mainly determine accord follow criterion : - Respiratory physician work respiratory department tier 3 hospital - To include expected number patient maximum 12 month , physician manage reasonable number asthma , COPD ACOS age 40 persistent airflow limitation ( post-BD FEV1/FVC &lt; 0.7 ) . - Physicians patient ' spirometric data available patient 's medical file ( post-BD FEV1 % pred post-BD FEV1/FVC ) . This NIS collect data ( e.g . medical record , patient physician-reported data ) 2000 consecutive outpatient persistent airflow limitation ( post-BD FEV1/FVC &lt; 0.7 ) 20 site China one year . Each site recruit 50-150 patient successively . The data collect routine clinical practice . The treatment examination determine treat physician . The data expect reflect actual situation ACOS . The study population 2000 outpatient , men woman , age 40 , clinical diagnosis asthma , COPD ACOS persistent airflow limitation（post-BD FEV1/FVC &lt; 0.7）in China Q4,2015 Q3,2016 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<criteria>Outpatients , age ≥ 40 year Clinically diagnose asthma , COPD/chronic bronchitis/emphysema ACOS least 12 month With persistent airflow limitation ( postBD FEV1/FVC &lt; 0.7 ) Signed informed consent form Have involve clinical trial within 3 month Having respiratory disease influence airflow , lung cancer , tuberculosis , pneumonia , bronchiectasis , etc With acute exacerbation Inability understand study procedure inability/reluctance answer questionnaire judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ACOS</keyword>
</DOC>